Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedFooter revision updated from v3.5.3 to v3.5.4, indicating a minor site update. No changes to the study details or page structure are evident.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s displayed software/content “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a release/version change without altering the underlying study information.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded revisions dated 2026-04-13, 2026-03-23, and 2026-03 with Revision: v3.5.2, and removed revisions dated 2025-12-23, 2025-12-04, and 2025-12 with Revision: v3.5.0. The changes pertain to the site's revision history and do not affect the study page content.SummaryDifference0.1%

- Check51 days agoChange DetectedPadua, Italy was replaced with Padova, Italy in the study locations.SummaryDifference0.1%

- Check65 days agoChange DetectedNaples, Italy was added as a location and Napoli, Italy was removed; the revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.